Brief by Shorts91 Newsdesk / 12:39pm on 02 Sep 2025,Tuesday India Global
US President Donald Trump has proposed tariffs of up to 200% on imported medicines, citing national security and the need to boost domestic production. Experts warn the move could raise drug prices by 10–14% and cause shortages, especially for generics that make up most US prescriptions. Low-income and elderly patients may be hit hardest. India, a top supplier of affordable generics, has been excluded from immediate enforcement as its medicines are vital for US healthcare. However, analysts say future policy changes could affect India’s $25 billion pharma exports. Legal battles and industry pushback may delay the tariff plan. (PC: AP)
